Cetera Advisor Networks’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$69.7M Buy
89,539
+9,628
+12% +$6.85M 0.34% 58
2023
Q4
$46.6M Buy
79,911
+6,614
+9% +$3.86M 0.26% 83
2023
Q3
$39.4M Buy
73,297
+1,521
+2% +$784K 0.25% 86
2023
Q2
$33.7M Buy
71,776
+2,809
+4% +$1.18M 0.23% 91
2023
Q1
$23.7M Buy
68,967
+6,985
+11% +$2.36M 0.17% 132
2022
Q4
$22.7M Buy
61,982
+18,325
+42% +$6.5M 0.18% 126
2022
Q3
$14.1M Buy
43,657
+4,408
+11% +$1.4M 0.18% 133
2022
Q2
$12.7M Buy
39,249
+2,606
+7% +$782K 0.16% 142
2022
Q1
$10.5M Buy
36,643
+1,205
+3% +$310K 0.13% 170
2021
Q4
$9.79M Buy
35,438
+527
+2% +$134K 0.12% 185
2021
Q3
$8.07M Sell
34,911
-1,426
-4% -$352K 0.11% 199
2021
Q2
$8.34M Buy
36,337
+7,369
+25% +$1.48M 0.12% 183
2021
Q1
$5.41M Sell
28,968
-635
-2% -$124K 0.11% 182
2020
Q4
$5M Sell
29,603
-133
-0.4% -$19.9K 0.12% 178
2020
Q3
$4.4M Buy
29,736
+1,689
+6% +$261K 0.11% 177
2020
Q2
$4.61M Buy
28,047
+790
+3% +$121K 0.12% 168
2020
Q1
$3.78M Sell
27,257
-763
-3% -$105K 0.12% 172
2019
Q4
$3.69M Buy
28,020
+322
+1% +$37.3K 0.1% 195
2019
Q3
$3.1M Buy
27,698
+198
+0.7% +$22K 0.09% 197
2019
Q2
$3.04M Buy
27,500
+1,852
+7% +$218K 0.09% 199
2019
Q1
$3.33M Buy
25,648
+1,569
+7% +$191K 0.11% 173
2018
Q4
$2.79M Sell
24,079
-2,663
-10% -$297K 0.11% 177
2018
Q3
$2.87M Buy
26,742
+4,544
+20% +$454K 0.1% 176
2018
Q2
$1.9M Buy
22,198
+1,279
+6% +$105K 0.09% 177
2018
Q1
$1.62M Sell
20,919
-2,642
-11% -$213K 0.07% 223
2017
Q4
$1.99M Sell
23,561
-520
-2% -$44.2K 0.08% 209
2017
Q3
$2.06M Buy
24,081
+2,253
+10% +$185K 0.09% 188
2017
Q2
$1.79M Sell
21,828
-912
-4% -$74.4K 0.08% 213
2017
Q1
$1.91M Sell
22,740
-2,410
-10% -$193K 0.09% 205
2016
Q4
$1.85M Sell
25,150
-5,950
-19% -$443K 0.1% 198
2016
Q3
$2.5M Buy
31,100
+6,288
+25% +$503K 0.1% 200
2016
Q2
$1.96M Sell
24,812
-212
-0.8% -$16K 0.11% 181
2016
Q1
$1.8M Sell
25,024
-501
-2% -$37.9K 0.11% 184
2015
Q4
$2.15M Sell
25,525
-29
-0.1% -$2.41K 0.14% 165
2015
Q3
$2.13M Buy
25,554
+3,451
+16% +$291K 0.15% 149
2015
Q2
$1.61M Hold
22,103
0.1% 205
2015
Q1
$1.61M Buy
22,103
+17
+0.1% +$1.21K 0.1% 205
2014
Q4
$1.53M Sell
22,086
-2,117
-9% -$143K 0.11% 197
2014
Q3
$1.56M Buy
24,203
+143
+0.6% +$9.05K 0.11% 194
2014
Q2
$1.49M Sell
24,060
-136
-0.6% -$8.11K 0.1% 225
2014
Q1
$1.43M Buy
24,196
+5,681
+31% +$317K 0.1% 210
2013
Q4
$941K Buy
18,515
+644
+4% +$32.2K 0.07% 280
2013
Q3
$900K Buy
17,871
+29
+0.2% +$1.52K 0.08% 251
2013
Q2
$876K Buy
+17,842
New +$971K 0.09% 225

Other funds holding LLY

Cetera Advisor Networks's LLY Position: Q1 2024 in Review

Cetera Advisor Networks increased its Eli Lilly (LLY) stake by 12% in Q1 2024, buying an estimated $6.85M and bringing the position to 89,539 shares worth $69.7M. The position accounts for 0.34% of the portfolio, ranked #58.

Cetera Advisor Networks first reported a position in LLY in Q2 2013 and has held it in 44 quarters since. 3,461 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

  • Cetera Advisor Networks held 89,539 shares of Eli Lilly worth $69.7M as of Q1 2024.
  • Cetera Advisor Networks bought 9,628 Eli Lilly shares in Q1 2024, an estimated $6.85M.
  • Eli Lilly made up 0.34% of Cetera Advisor Networks's portfolio in Q1 2024, its #58 holding.
  • Cetera Advisor Networks first reported a position in Eli Lilly in Q2 2013 and has held it in 44 quarters since.
  • 3,461 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.